NGM Bio’s NGM282 succeeds in nonalcoholic steatohepatitis phase 2 trial

Read more

Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib

Read more

Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara (sarilumab)

Read more

Recipharm delivers first serialised batch to Saudi Arabia

Read more

Top 5 Reasons to Outsource Your Site Payments Process

Read more

J&J buys 3D-printing tech to create bone-healing implants

Read more

Novartis’s CTL019 receives FDA Breakthrough Therapy designation

Read more

Phase 1/2 Clinical Trial of Agenus’ anti-PD-1 Antibody Begins

Read more

uniQure Announces It Will Not Seek Marketing Authorization Renewal for Glybera in Europe

Read more

H3 Biomedicine Extends Collaboration with Foundation Medicine to Develop Precision Therapies for Cancer

Read more